Validation of 68Ge/68Ga generator processing by chemical purification for routine clinical application of 68Ga-DOTATOC

被引:90
作者
Asti, Mattia [1 ]
De Pietri, Giovanni [1 ]
Fraternali, Alessandro [1 ]
Grassi, Elisa [2 ]
Sghedoni, Roberto [2 ]
Floroni, Federica [2 ]
Roesch, Frank [3 ]
Versari, Annibale [1 ]
Salvo, Diana [1 ]
机构
[1] Santa Maria Nuova Hosp, Dept Nucl Med, Reggio Emilia, Italy
[2] Santa Maria Nuova Hosp, Dept Med Phys, Reggio Emilia, Italy
[3] Johannes Gutenberg Univ Mainz, Inst Nucl Chem, D-55128 Mainz, Germany
关键词
Ge-68/Ga-68; generator; postprocessing of eluates; cation-exchange chromotography; DOTATOC; PET;
D O I
10.1016/j.nucmedbio.2008.04.006
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Imaging of somatostatin receptor expressing tumors has been greatly enhanced by the use of Ga-68-DOTATOC and PET/CT. Methods: In this work, a purification method for the Ge-68/Ge-68 generator eluate and a method to produce Ga-68-DOTATOC suitable for clinical use were evaluated. The generator eluate was purified and concentrated on a cation-exchange cartridge in HCl/acetone media. The efficacy of this procedure in eliminating metal impurities from the Ga-68 soultion was investigated by ICP-Ms. The radiotracer quality was evaluated by radio-TLC, and gamma-ray spectrometry. Resutls: Ga-68-DOTATOC preparations (n=33) were carried out with a mean synthesis yield of 59.3 +/- 2.8% (not corrected for decay) and a batch activity ranging from >95% of the Fe(III), Zn(II) and Mn(II) were eliminated from the solution. Conclusions: Ga-68-DOTATOC produced with this method can be efficiently used in nuclear medicine departments for PET evaluations. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:721 / 724
页数:4
相关论文
共 14 条
[1]   Radiolabelling DOTA-peptides with 68Ga [J].
Breeman, WAP ;
de Jong, M ;
de Blois, E ;
Bernard, BF ;
Konijnenberg, M ;
Krenning, EP .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (04) :478-485
[2]   Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours [J].
Buchmann, I. ;
Henze, M. ;
Engelbrecht, S. ;
Eisenhut, M. ;
Runz, A. ;
Schaefer, M. ;
Schilling, T. ;
Haufe, S. ;
Herrmann, T. ;
Haberkorn, U. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (10) :1617-1626
[3]   A fully automated synthesis for the preparation of 68Ga-labelled peptides [J].
Decristoforo, Clemens ;
Knopp, Roger ;
von Guggenberg, Elisabeth ;
Rupprich, Marco ;
Dreger, Thorsten ;
Hess, Andre ;
Virgolini, Irene ;
Haubner, Roland .
NUCLEAR MEDICINE COMMUNICATIONS, 2007, 28 (11) :870-875
[4]   68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and CT [J].
Gabriel, Michael ;
Decristoforo, Clemens ;
Kendler, Dorota ;
Dobrozemsky, Georg ;
Heute, Dirk ;
Uprimny, Christian ;
Kovacs, Peter ;
Von Guggenberg, Elisabeth ;
Bale, Reto ;
Virgolini, Irene J. .
JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) :508-518
[5]  
Henze M, 2001, J NUCL MED, V42, P1053
[6]   Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC:: preliminary data [J].
Hofmann, M ;
Maecke, H ;
Börner, AR ;
Weckesser, E ;
Schöffski, P ;
Oei, ML ;
Schumacher, J ;
Henze, M ;
Heppeler, A ;
Meyer, GJ ;
Knapp, WH .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (12) :1751-1757
[7]  
Kowalski Jorg, 2003, Mol Imaging Biol, V5, P42, DOI 10.1016/S1536-1632(03)00038-6
[8]  
MARCHOL M, 1982, ION EXCHANGERS ANAL
[9]   68Ga-labelled DOTA-derivatised peptide ligands [J].
Meyer, GJ ;
Mäcke, H ;
Schuhmacher, J ;
Knapp, WH ;
Hofmann, M .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (08) :1097-1104
[10]  
Schinkel AFL, 2003, J NUCL MED, V44, P877